Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
MRNA | Moderna, Inc. | 0.82% | 132.30 | 0.0% | $1592.67m | |
OCGN | Ocugen, Inc. | -14.25% | 8.97 | 0.0% | $993.97m | |
NVAX | Novavax, Inc. | -13.89% | 158.10 | 92.9% | $973.00m | |
AMGN | Amgen, Inc. | -0.91% | 221.91 | 1.3% | $586.84m | |
REGN | Regeneron Pharmaceuticals, Inc. | 0.59% | 449.38 | 2.7% | $521.53m | |
VRTX | Vertex Pharmaceuticals, Inc. | -0.31% | 207.79 | 1.9% | $503.86m | |
GILD | Gilead Sciences, Inc. | 0.77% | 63.23 | 1.0% | $499.99m | |
ILMN | Illumina, Inc. | -4.03% | 399.61 | 3.5% | $482.11m | |
BIIB | Biogen, Inc. | -1.14% | 263.57 | 1.7% | $367.21m | |
ALXN | Alexion Pharmaceuticals, Inc. | 0.18% | 148.46 | 2.0% | $360.83m | |
CRSP | CRISPR Therapeutics AG | -3.02% | 115.49 | 0.6% | $268.32m | |
BNGO | BioNano Genomics, Inc. | -19.30% | 6.90 | 0.0% | $265.49m | |
EXAS | EXACT Sciences Corp. | -4.39% | 121.02 | 18.4% | $224.11m | |
SGEN | Seagen Inc. | -1.68% | 145.45 | 5.8% | $204.38m | |
VXRT | Vaxart, Inc. | -6.92% | 5.92 | 0.0% | $174.35m |
Company Profile
Mateon Therapeutics, Inc. is a biopharmaceutical company. It engages in developing anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. The firm operates through the following segments: PointR, Mateon/Oxigene and Oncotelic. The PointR segment develops vision grid/cluster computing/AI to support drug development. The Mateon/Oxigene segment develops Vascular Disrupting Agent (CA4P and Oxi4503). The Oncotelic segment develops OT-101, an antisense against TGF-beta- for the treatment of cancers. Mateon Therapeutics was founded in 1988 and is headquartered in Agoura Hills, CA.